Helix BioMedix Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Helix BioMedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013545
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Helix BioMedix Inc (Helix) is a dermatology and consumer skin care products company. It develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmeceuticals, anti-aging skin care products, acne treatment, wound healing and other topical anti-infective treatments. The company is also developing drug candidate peptides for acne, methicillin-resistant staphylococcus aureus (MRSA) and other dermatological conditions. Helix is partnered with contract research organizations, fine ingredient suppliers and manufacturers. The company offers its cosmeceutical active ingredient through its distribution partners. Helix is headquartered in Bothell, Washington, the US.

Helix BioMedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helix BioMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Helix Biomedix Completes Private Placement Of Shares For US$0.5 Million 10
Helix BioMedix Completes Private Placement Of US$0.6 Million 11
Helix BioMedix Completes Private Placement Of US$5.98 Million 12
Helix BioMedix Inc – Key Competitors 13
Helix BioMedix Inc – Key Employees 14
Helix BioMedix Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Jul 24, 2017: EverlyWell Partners with Helix to Launch New Suite of DNA Tests to Provide Deeper Insights about Health and Wellness 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Helix BioMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Helix BioMedix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Helix Biomedix Completes Private Placement Of Shares For US$0.5 Million 10
Helix BioMedix Completes Private Placement Of US$0.6 Million 11
Helix BioMedix Completes Private Placement Of US$5.98 Million 12
Helix BioMedix Inc, Key Competitors 13
Helix BioMedix Inc, Key Employees 14

★海外企業調査レポート[Helix BioMedix Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Penske Corporation:企業の戦略的SWOT分析
    Penske Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Clientele Limited:企業の戦略・SWOT・財務分析
    Clientele Limited - Strategy, SWOT and Corporate Finance Report Summary Clientele Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Top Glove Corporation Berhad (TOPGLOV):医療機器:M&Aディール及び事業提携情報
    Summary Top Glove Corporation Berhad (Top Glove) is a manufacturer and distributor of rubber gloves. The company’s products include nitrile gloves, vinyl gloves, latex gloves, surgical gloves, clean room gloves, household gloves, polyisoprene gloves, and cast polyethylene gloves. It also provides th …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dominium S.A.:企業の戦略・SWOT・財務情報
    Dominium S.A. - Strategy, SWOT and Corporate Finance Report Summary Dominium S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Microbot Medical Inc (MBOT):製薬・医療:M&Aディール及び事業提携情報
    Summary Microbot Medical Inc (Microbot), formerly StemCells Inc, a subsidiary of Stem Cell Sciences UK Ltd, is a medical device company that develops pharmaceutical, cell based therapeutics and related tools. The company provides research on products for spinal cord injury, thoracic injury, cervical …
  • National Australia Bank Private Wealth:企業の戦略・SWOT・財務情報
    National Australia Bank Private Wealth - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Private Wealth - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • The Netherlands Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene reg …
  • Alliant Insurance Services, Inc.:企業のM&A・事業提携・投資動向
    Alliant Insurance Services, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alliant Insurance Services, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Gildan Activewear Inc.:企業の戦略・SWOT・財務情報
    Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report Summary Gildan Activewear Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Daicel Corp (4202):企業の財務・戦略的SWOT分析
    Daicel Corp (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Humanwell Healthcare (Group) Co Ltd (600079)-医療機器分野:企業M&A・提携分析
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. It provides anesthetics, b …
  • ADDvise Group AB (ADDV A):企業の財務・戦略的SWOT分析
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • PLT Health Solutions Inc:企業の戦略・SWOT・財務分析
    PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆